Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “China Virus Filtration Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024” report has been added…
Philip Burchard to become Chairman of the Merz Shareholders Council in addition to his position as CEO of the company…
DUBLIN–(BUSINESS WIRE)–The “Acetazolamide Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025” report has been added to…
DUBLIN–(BUSINESS WIRE)–The “Global Stem Cell and Regenerative Therapy Market: A Research Outlook” report has been added to ResearchAndMarkets.com’s offering. Growth…
FOSTER CITY, Calif. & MECHELEN, Belgium–(BUSINESS WIRE)–Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced…
With 100% ownership, Company expects to complete buildout of vertically integrated operations, including its cultivation and manufacturing facility in Aurora…
Combined company uniquely suited to drive precision oncology forward with RNA technologies to identify oncology drug responder populations DURHAM, N.C.–(BUSINESS…
On the West Coast, City of Hope is the first institution to open the Kite-sponsored trial DUARTE, Calif.–(BUSINESS WIRE)–#CityofHope–The first-in-human,…
Medical Marijuana, the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, record revenue of $20.7 million in the second quarter of 2019, a 30.8% increase over the same quarter in 2018.
Trovagene will present new clinical data from its Phase 2 trial of onvansertib, in combination with Zytiga (abiraterone acetate)/prednisone, in…